Recent studies into the drug are uncovering remarkable potential beyond current indication for type 2 condition. Experts are actively investigating how this GLP-1 receptor agonist impacts metabolic health, the heart, and possibly cognitive function. The results indicate a broad array of future treatments, driving more exploration and research proje